Literature DB >> 19618755

An update on acute ischemic stroke therapies.

Aimee Joy Szewka1, Shyam Prabhakaran.   

Abstract

Given its short therapeutic time window, successful ischemic stroke therapy requires a multi-disciplinary and streamlined approach. Intravenous recombinant tissue plasminogen activator remains the most efficacious treatment available. New therapies and advances in the understanding comorbidities associated with stroke have reshaped and expanded traditional treatment.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19618755

Source DB:  PubMed          Journal:  Compr Ther        ISSN: 0098-8243


  2 in total

1.  Punicalagin attenuated cerebral ischemia-reperfusion insult via inhibition of proinflammatory cytokines, up-regulation of Bcl-2, down-regulation of Bax, and caspase-3.

Authors:  Lavanya Yaidikar; Santhrani Thakur
Journal:  Mol Cell Biochem       Date:  2015-01-03       Impact factor: 3.396

2.  Synergism and rules from combination of Baicalin, Jasminoidin and Desoxycholic acid in refined Qing Kai Ling for treat ischemic stroke mice model.

Authors:  Jian Li; Run-guo Wu; Fan-yun Meng; Zhong Wang; Chang-ming Wang; Yong-yan Wang; Zhan-jun Zhang
Journal:  PLoS One       Date:  2012-09-26       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.